Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions

Documenti analoghi

• Repotrectinib: Redefining the therapeutic landscape for patients with ROS1 fusion‐driven non‐small cell lung cancer
  di: Antoine Desilets, et al.
  Pubblicazione: (2024)
• Multiomic characterization of small cell lung cancer: Real‐world insights into therapeutic opportunities
  di: Sonam Puri, et al.
  Pubblicazione: (2026)
• The current therapeutic cancer vaccines landscape in non‐small cell lung cancer
  di: Shaoyi Chen, et al.
  Pubblicazione: (2024)
• ILT4 facilitates angiogenesis in non‐small cell lung cancer
  di: Shuyun Wang, et al.
  Pubblicazione: (2024)
• The changing landscape of small cell lung cancer
  di: Giordano Fabricio Cittolin‐Santos, et al.
  Pubblicazione: (2024)